Selected publications 2018 Journal Articles Refereed Targeting TrkB with a Brain-Derived Neurotrophic Factor Mimetic Promotes Myelin Repair in the Brain. Journal of Neuroscience. 38. 2018 2017 Journal Articles Refereed A Brain-Derived Neurotrophic Factor-Based p75(NTR) Peptide Mimetic Ameliorates Experimental Autoimmune Neuritis Induced Axonal Pathology and Demyelination 2017 2016 Journal Articles Refereed Engineering of a Novel Simplified Human Insulin-Like Peptide 5 Agonist. Journal of Medicinal Chemistry. 59. 2016 The C-terminus of the B-chain of human insulin-like peptide 5 is critical for cognate RXFP4 receptor activity. Amino Acids. 48. 2016 2015 Journal Articles Refereed Cellular Disulfide Bond Formation in Bioactive Peptides and Proteins. International Journal of Molecular Sciences. 16. 2015 2014 Journal Articles Refereed TDP6, a brain-derived neurotrophic factor-based trkB peptide mimetic, promotes oligodendrocyte myelination. Molecular and Cellular Neurosciences. 63. 2014 2013 Journal Articles Refereed A small peptide mimetic of brain-derived neurotrophic factor promotes peripheral myelination. Journal of Neurochemistry. 125. 2013 2012 Journal Articles Refereed The structural determinants of insulin-like peptide 3 activity. Frontiers in Endocrinology. 3. 2012 2011 Journal Articles Refereed Design and Development of Analogues of Dimers of Insulin-like Peptide 3 B-Chain as High-Affinity Antagonists of the RXFP2 Receptor. Biopolymers. 96. 2011 2010 Journal Articles Refereed Effect of helix-promoting strategies on the biological activity of novel analogues of the B-chain of INSL3. Amino Acids. 38. 2010 Role of the intra-A-chain disulfide bond of insulin-like peptide 3 in binding and activation of its receptor, RXFP2. Peptides. 31. 2010 Synthesis of "Difficult" Fluorescence Quenched Substrates of Granzyme C. International Journal of Peptide Research and Therapeutics. 16. 2010 2009 Research Book Chapters Development of lanthanide-labelled human INSL3 as an alternative probe to radioactively-labelled INSL3 for use in bioassays. Relaxin and Related Peptides: Fifth International Conference, Ann NY Acad Sci Vol 1160. Wiley-Blackwell Publishing. 2009 The chemistry and biology of insulin-like peptide 3, a novel member of the insulin superfamily.. Bioactive Peptides. Taylor & Francis Ltd. 2009 Journal Articles Refereed Brain-derived neurotrophic factor regulates early postnatal developmental cell death of dopamine neurons of the substantia negra in vivo. Molecular and Cellular Neurosciences. 41. 2009 Modified low molecular weight cyclic peptides as mimetics of BDNF with improved potency, proteolytic stability and transmembrane passage in vitro. Bioorganic & Medicinal Chemistry. 17. 2009 2008 Journal Articles Refereed Design of a conformationally-defined and proteolytically stable circular mimetic of brain-derived neurotrophic factor. Journal of Biological Chemistry. 283. 2008 Solid-Phase Synthesis of Europium-Labeled Human INSL3 as a Novel Probe for the Study of Ligand-Receptor Interactions. Bioconjugate Chemistry. 19. 2008 Understanding the cardioprotective effects of flavonols: Discovery of relaxant flavonols without antioxidant activity. Journal of Medicinal Chemistry. 51. 2008 2007 Journal Articles Refereed 2-Methoxyestradiol - a unique blend of activities generating a new class of anti-tumor/anti-inflammatory agents. Drug Discovery Today: Therapeutic Strategies. 12. 2007 Carbohydrate-based VEGF inhibitors. European Journal of Organic Chemistry. 2007. 2007 Design, synthesis and pharmacological evaluation of cyclic mimetics of the insulin-like peptide 3 (INSL3) B-chain. Journal of Peptide Science. 13. 2007 Conference Papers Refereed Molecular pathways for the lymphangiogenesis and their role in human disease. 2007 2006 Journal Articles Refereed Analogs of insulin-like peptide 3 (INSL3) B-Chain are LGR8 antagonists in vitro and in vivo. Journal of Biological Chemistry. 281. 2006 Current strategies for modulating lymphangiogenesis signalling pathways in human disease.. Current Medicinal Chemistry. 13. 2006 Novel monocyclic and bicyclic loop mimetics of brain-derived neurotrophic factor. Journal of Peptide Science. 12. 2006 Solution structure and characterization of the receptor binding surface of insulin-like peptide 3*. Journal of Biological Chemistry. 281. 2006 Conference Papers Refereed Design of Conformationally-Constrained Peptides as Mimetics of Cellular Growth Factors 2006 Patents VEGF-D/VEG-C/VEGF peptidomimetic inhibitor 2006 2005 Journal Articles Refereed Conformationality constrained single-chain peptide mimics of relaxin B-chain secondary structure. Journal of Peptide Science. 11. 2005 The next generation of phosphodiesterase inhibitors: Structural clues to ligand and substrate selectivity of phosphodiesterases. Journal of Medicinal Chemistry. 48. 2005 2004 Journal Articles Refereed A novel approach to the regioselective synthesis of a disulfide-linked heterodimeric bicyclic peptide mimetic of brain-derived neurotrophic factor. Tetrahedron Letters. 45. 2004 Molecular targeting of lymphatics for therapy. Current Pharmaceutical Design. 10. 2004 2003 Research Book Chapters Mechanisms of neurodegenerative diseases. Molecular pathomechanisms and new trends in drug research. Taylor & Francis Ltd. 2003 Journal Articles Refereed Design of potent peptide mimetics of brain-derived neurotrophic factor. Journal of Biological Chemistry. 278. 2003 2002 Journal Articles Refereed 2-Methoxyestradiol and analogs as novel antiproliferative agents: analysis of three-dimensional quantitative structure-activity relationships for DNA synthesis inhibition and estrogen receptor binding. Molecular Pharmacology. 61. 2002 2001 Research Book Chapters Oestradiol Metabolites. Effects on Airway Remodelling. New Drugs for Asthma, Allergy and COPD. Karger AG. 2001
Investigator on Grant DESIGN AND SYNTHESIS OF TRICYCLIC DIMER PEPTIDE MIMETICS OF BDNF AS POTENTIAL REMYELINATING THERAPEUTICS TO TREAT MULTIPLE SCLEROSIS (Project Grant) awarded by MULTIPLE SCLEROSIS RESEARCH AUSTRALIA LTD 2017 - 2019 NOVEL STRATEGIES TO PROMOTE MYELIN REPAIR IN THE BRAIN (Project Grants) awarded by NHMRC 2016 - 2018 Towards new drugs for multiple sclerosis (Science & Medicine Grants) awarded by THE CASS FOUNDATION LTD 2016 - 2017 Towards new drugs for multiple sclerosis: Synthetic strategies for the synthesis of novel peptide BDNF-mimetics (Incubator Grant) awarded by MULTIPLE SCLEROSIS RESEARCH AUSTRALIA LTD 2016 A NEW STRATEGY FOR TREATING DEMYELINATING DISEASES (Project Grants) awarded by NHMRC 2014 - 2017 Development of INSL5 peptide analogues as novel therapeutics (Linkage Projects) awarded by AUST RESEARCH COUNCIL 2012 - 2016 Brain derived neurotrophic factor applied locally to the ear to improve hearing (Project Grants) awarded by GARNETT PASSE & RODNEY WILLIAMS MEMORIAL FUND 2012 - 2015 Enhancing the clinical potential of relaxin (Project Grants) awarded by NHMRC 2012 - 2014 Examination of BDNF mimetics as promoters of central nervous system myelination (Incubator Grant) awarded by MULTIPLE SCLEROSIS RESEARCH AUSTRALIA LTD 2012 - 2013 New treatments for cancer (Project Grants) awarded by NHMRC 2009 - 2011 Structure-function relationship of human insulin-like peptide 3. (Project Grants) awarded by NHMRC 2008 - 2010 Structure-function relationship of human relaxins. (Project Grants) awarded by NHMRC 2008 - 2010 DEVELOPMENT OF EPHA4 PEPTIDE INHIBITORS FOR THE TREATMENT OF NEUROTRAUMA (Victorian Neurotrauma Initiative) awarded by TRANSPORT ACCIDENT COMMISSION 2007 - 2009 Structure-function and domain minimization of insulin-like peptide 3, a novel member of the insulin superfamily (Project Grants) awarded by NHMRC 2005 - 2007